Average Co-Inventor Count = 2.52
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. New York University (13 from 1,627 patents)
2. H. Lee Moffitt Cancer Center and Research Institute, Inc. (1 from 290 patents)
3. Signal Pharmaceuticals, Inc. (1 from 169 patents)
14 patents:
1. 11583525 - Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer
2. 9261497 - Method of treating cancer with modulators of SCFSkp2
3. 8778905 - USP47 inhibitors and methods to induce apoptosis
4. 8753830 - Methods to identify compounds useful for tumor sensitization to DNA damage
5. 8586297 - Modulating the Cdc14B-Cdh1-Plk1 axis and methods for sensitizing target cells to apoptosis
6. 8551969 - Methods to identify compounds useful for tumor sensitization to DNA damage
7. 8318437 - USP47 inhibitors and methods to induce apoptosis
8. 8216835 - Modulating the CDC14B-CDH1-PLK1 axis and methods for sensitizing target cells to apoptosis
9. 8119421 - Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
10. 8093043 - β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
11. 8076309 - USP47 inhibtors and methods to induce apoptosis
12. 7439032 - Methods to identify compounds useful for tumor sensitization to DNA damage
13. 7037936 - Compounds useful for the treatment of cancer, compositions thereof and methods therewith
14. 6720181 - Ubiquitin ligases as therapeutic targets